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Three-chamber chest drain system in the COVID-19 era: is there  
a risk of further transmission? 
To the Editor
Once a chest tube is placed, during an emer-
gency or after thoracic surgery, a Chest Drain 
System (CDS) is attached. The most commonly 
used CDSs are the analogic three-chamber pla-
stic units, consisting respectively in a drainage, 
a water seal and a suction chamber [1].
The three chambers are in communication 
and the water seal prevents the air returning to 
the pleural space during inspiration. As a CDS 
is set up, the water seal is filled with standard 
saline solution or water. If your choice is a wet 
CDS the suction column also has to be filled up 
to the desired level.
The dramatic outspread of coronavirus dise-
ase 2019 (COVID-19) has changed the manage-
ment of patients undergoing thoracic surgery and, 
consequently, the habits of a Thoracic Surgery 
ward and operating theatre. Unfortunately, CO-
VID-19 transmission to patients and health care 
staff is well reported [2]. We would like to arise 
concerns about the chances of infection for both 
nurses and surgeons when using standard CDS 
in COVID-19 patients. 
This is mainly for three reasons: firstly, in the 
case of a broken or overturned CDS there could 
be a direct contamination by fluids from the chest 
cavity. Secondly, we cannot exclude that aerosol 
transmission occurs from within the CDS to the 
surrounding atmosphere [3]. Finally, there can 
be contamination while dealing with the suction 
system, because the CDS may be connected to 
the external wall vacuum by a plastic tube. As 
previously described, a CDS is a system of three 
plastic chambers and viable coronavirus has been 
detected on plastic surfaces up to 72 hours after 
application [4]. 
For all these reasons the safety of a standard 
three plastic chamber CDS in a COVID-19 patient 
has to be questioned in its present form, without 
appropriate precautions. The best means of pro-
tecting physicians and nurses from COVID-19 in-
fection during daily ward activities shouldn’t 
be the cleaning of the CDS. Once connected to 
the chest tube(s) the CDS is placed on the floor 
and periodical cleaning with alcoholic solutions 
(e.g. twice a day) exposes the operators to further 
contamination. 
A reasonable way to reduce the possibility 
of contamination is to substitute the fluids com-
monly used to fill the water-seal chamber (for 
both dry and wet CDS) and the suction chamber 
(for the wet CDS only). We advocate the use of an 
alcohol-based solution (ethanol 62–71%) instead 
of water/saline solution to fill both the water-seal 
and suction chamber in order to minimize the risk 
of aerosol diffusion.
Ethanol-based solutions are found to be more 
effective in the prevention of further spread of 
COVID-19 on inanimate surfaces if compared to 
chlorhexidine and other biocidal agents [5]. The 
solution has to maintain the fluid properties of 
water to ensure the correct functioning of the 
CDS. Finally, the risk of alcohol evaporation and 
direct inhalation by the patient into the chest 
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cavity during inspiration is negated by the uni-
directionality of the system. However, further 
studies are needed to confirm our advice.
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